Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [31] Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis
    Hashimoto, Motomu
    Fujii, Takao
    Hamaguchi, Masahide
    Furu, Moritoshi
    Ito, Hiromu
    Terao, Chikashi
    Yamamoto, Keiichi
    Yamamoto, Wataru
    Matsuo, Takashi
    Mori, Masato
    Ohmura, Koichiro
    Kawabata, Hiroshi
    Mimori, Tsuneyo
    [J]. PLOS ONE, 2014, 9 (05):
  • [32] A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
    Taskin, Mine Islimye
    Gungor, Aysenur Cakir
    Adali, Ertan
    Yay, Arzu
    Onder, Gozde Ozge
    Inceboz, Umit
    [J]. REPRODUCTIVE SCIENCES, 2016, 23 (05) : 662 - 669
  • [33] A Humanized Anti-Interleukin 6 Receptor Monoclonal Antibody, Tocilizumab, for the Treatment of Endometriosis in a Rat Model
    Mine Islimye Taskin
    Aysenur Cakir Gungor
    Ertan Adali
    Arzu Yay
    Gozde Ozge Onder
    Umit Inceboz
    [J]. Reproductive Sciences, 2016, 23 : 662 - 669
  • [34] Anti-IL6 Vaccination inhibits SSc
    不详
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (06): : 487 - 487
  • [35] Efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody; in patients with polyarticular or oligoarticular onset juvenile idiopathic arthritis.
    Imagawa, Tomoyuki
    Mori, Masaaki
    Takei, Syuji
    Kawano, Yoshifumi
    Iwata, Naomi
    Miyoshi, Mari
    Murata, Takuji
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    Yokota, Shumpei
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S168 - S168
  • [36] The increase of CD56 high NK cells and activated Treg-cells in patient with neuromyelitis optica after treatment with anti-IL-6R antibody tocilizumab
    Matsuoka, T.
    Chiba, A.
    Aranami, T.
    Nakamura, M.
    Sato, W.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 347 - 347
  • [37] Blockade of IL-6 signaling in neuromyelitis optica
    Araki, Manabu
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 130
  • [38] Anti-IL6 receptor therapy: Rationale and early results in rheumatoid arthritis
    Maini, RN
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 26
  • [39] ANTITUMOR EFFECT OF HUMANIZED ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB) ON GLIOMA CELL PROLIFERATION
    Kudo, Mareina
    Jono, Hirofumi
    Shinriki, Satoru
    Yano, Shigetoshi
    Nakamura, Hideo
    Makino, Keishi
    Hide, Takuichiro
    Muta, Daisuke
    Ueda, Mitsuharu
    Ota, Kazutoshi
    Ando, Yukio
    Kuratsu, Jun-ichi
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 966 - 966
  • [40] Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Kim, Ho Jin
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (03): : 355 - 368
12345